Analysts Anticipate Colgate-Palmolive (CL) Will Post Quarterly Sales of $4.01 Billion

Brokerages expect Colgate-Palmolive (NYSE:CL) to report $4.01 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have made estimates for Colgate-Palmolive’s earnings. The highest sales estimate is $4.09 billion and the lowest is $3.95 billion. Colgate-Palmolive posted sales of $3.76 billion in the same quarter last year, which would indicate a positive year over year growth rate of 6.6%. The firm is scheduled to issue its next quarterly earnings report before the market opens on Friday, April 27th.

According to Zacks, analysts expect that Colgate-Palmolive will report full-year sales of $16.26 billion for the current year, with estimates ranging from $16.09 billion to $16.43 billion. For the next fiscal year, analysts anticipate that the company will report sales of $16.80 billion per share, with estimates ranging from $16.62 billion to $16.99 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side research analysts that follow Colgate-Palmolive.

How to Become a New Pot Stock Millionaire

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 26th. The company reported $0.75 earnings per share for the quarter, hitting the Zacks’ consensus estimate of $0.75. Colgate-Palmolive had a net margin of 13.10% and a return on equity of 1,716.69%. The business had revenue of $3.89 billion during the quarter, compared to analysts’ expectations of $3.92 billion. During the same period in the previous year, the company earned $0.75 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 4.6% on a year-over-year basis.

Several equities analysts recently commented on CL shares. BNP Paribas cut shares of Colgate-Palmolive from an “outperform” rating to an “underperform” rating in a research note on Tuesday, January 30th. Zacks Investment Research cut shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Tuesday, December 19th. Citigroup upped their target price on shares of Colgate-Palmolive from $75.00 to $80.00 and gave the company a “neutral” rating in a research note on Tuesday, January 30th. Macquarie upgraded shares of Colgate-Palmolive from a “neutral” rating to an “outperform” rating and set a $81.00 target price for the company in a research note on Tuesday, December 19th. Finally, Barclays set a $75.00 target price on shares of Colgate-Palmolive and gave the company a “hold” rating in a research note on Thursday, March 15th. Four equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and four have issued a buy rating to the company’s stock. Colgate-Palmolive presently has an average rating of “Hold” and an average target price of $77.76.

In other news, CFO Dennis J. Hickey sold 5,651 shares of the stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $70.18, for a total value of $396,587.18. Following the completion of the transaction, the chief financial officer now owns 413,221 shares in the company, valued at approximately $28,999,849.78. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CTO Patricia Verduin sold 1,572 shares of the stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $70.17, for a total transaction of $110,307.24. Following the completion of the transaction, the chief technology officer now owns 50,675 shares of the company’s stock, valued at approximately $3,555,864.75. The disclosure for this sale can be found here. In the last 90 days, insiders sold 454,805 shares of company stock valued at $32,375,038. Corporate insiders own 1.02% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Swedbank bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth about $102,014,000. Boussard & Gavaudan Investment Management LLP grew its holdings in Colgate-Palmolive by 105.4% during the 3rd quarter. Boussard & Gavaudan Investment Management LLP now owns 177,167 shares of the company’s stock worth $12,940,000 after acquiring an additional 90,929 shares during the last quarter. Personal Capital Advisors Corp grew its holdings in Colgate-Palmolive by 4.6% during the 3rd quarter. Personal Capital Advisors Corp now owns 412,299 shares of the company’s stock worth $30,036,000 after acquiring an additional 18,271 shares during the last quarter. Nationwide Fund Advisors grew its holdings in Colgate-Palmolive by 0.3% during the 3rd quarter. Nationwide Fund Advisors now owns 248,289 shares of the company’s stock worth $18,088,000 after acquiring an additional 761 shares during the last quarter. Finally, Xact Kapitalforvaltning AB grew its holdings in Colgate-Palmolive by 1.3% during the 3rd quarter. Xact Kapitalforvaltning AB now owns 143,339 shares of the company’s stock worth $10,442,000 after acquiring an additional 1,884 shares during the last quarter. Institutional investors own 73.64% of the company’s stock.

NYSE:CL opened at $72.44 on Tuesday. The firm has a market cap of $62,673.39, a P/E ratio of 25.24, a P/E/G ratio of 2.70 and a beta of 0.74. Colgate-Palmolive has a one year low of $67.86 and a one year high of $77.91. The company has a quick ratio of 1.00, a current ratio of 1.36 and a debt-to-equity ratio of 27.02.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 15th. Stockholders of record on Friday, April 20th will be paid a $0.42 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.40. The ex-dividend date is Thursday, April 19th. This represents a $1.68 dividend on an annualized basis and a dividend yield of 2.32%. Colgate-Palmolive’s dividend payout ratio is currently 55.75%.

ILLEGAL ACTIVITY WARNING: “Analysts Anticipate Colgate-Palmolive (CL) Will Post Quarterly Sales of $4.01 Billion” was published by The Lincolnian Online and is the property of of The Lincolnian Online. If you are reading this news story on another publication, it was illegally copied and republished in violation of United States & international copyright law. The legal version of this news story can be viewed at https://www.thelincolnianonline.com/2018/04/17/analysts-anticipate-colgate-palmolive-cl-will-post-quarterly-sales-of-4-01-billion.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply